MOYES JAY M 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
MOYES JAY M
Director
Transactions
- Sale
Common Stock
2022-06-16$2.64/sh−22,858$60,370→ 38,322 total
Footnotes (2)
- [F1]These shares were sold pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.554 to $2.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price.